综述

回纹型风湿症的诊断与治疗进展

展开
  • 上海交通大学医学院附属瑞金医院风湿免疫科,上海 200025

收稿日期: 2022-01-20

  网络出版日期: 2022-08-09

本文引用格式

王凡, 叶俊娜, 杨程德 . 回纹型风湿症的诊断与治疗进展[J]. 内科理论与实践, 2022 , 17(03) : 258 -261 . DOI: 10.16138/j.1673-6087.2022.03.017

参考文献

[1] Hench P, Rosenberg EF. Palindromic rheumatism. A ‘new’ oft recurring disease of joints (arthritis, periarthritis, para-arthritis) apparently producing no articular residues. Report of thirty-four cases; its relation to angio-neural arthrosis’, ‘allergic rheumatism’ and rheumatoid arthritis[J]. Arch Int Med, 1944, 73: 293-321.
[2] Mankia K, Emery P. Palindromic rheumatism as part of the rheumatoid arthritis continuum[J]. Nat Rev Rheumatol, 2019, 15(11): 687-695.
[3] Ahn JK, Hwang J, Seo GH. Incidence and risk of developing rheumatic diseases in 19,724 patients with palindromic rheumatism in South Korea: a nationwide population-based study[J]. Joint Bone Spine, 2021, 88(3): 105128.
[4] Mankia K, Emery P. What can palindromic rheumatism tell us?[J]. Best Pract Res Clin Rheumatol, Feb, 2017, 31(1): 90-98.
[5] Barbieri P, Benedettini G, Ciompi ML, et al. Failure to detect a lymphocyte imbalance during acute attacks of palindromic rheumatism[J]. Clin Rheumatol, 1987, 6(1): 102-103.
[6] Cuervo A, Sanmartí R, Ramírez J, et al. Palindromic rheumatism: evidence of four subtypes of palindromic-like arthritis based in either MEFV or rheumatoid factor/ACPA status[J]. Joint Bone Spine, 2021, 88(6): 105235.
[7] Powell A, Davis P, Jones N, et al. Palindromic rheumatism is a common disease: comparison of new-onset palindromic rheumatism compared to new-onset rheumatoid arthritis in a 2-year cohort of patients[J]. J Rheumatol, 2008, 35(6): 992-994.
[8] Cabrera-Villalba S, Gomara MJ, Cañete JD, et al. Differing specificities and isotypes of anti-citrullinated peptide/protein antibodies in palindromic rheumatism and rheumatoid arthritis[J]. Arthritis Res Ther, 2017, 19(1): 141.
[9] Duquenne L, Chowdhury R, Mankia K, et al. The role of ultrasound across the inflammatory arthritis continuum: focus on “at-risk” individuals[J]. Front Med (Lausanne), 2020, 7: 587827.
[10] Cabrera-Villalba S, Ramirez J, Salvador G, et al. Is there subclinical synovitis in patients with palindromic rheumatism in the intercritical period? A clinical and ultrasonographic study according to anticitrullinated protein antibody status[J]. J Rheumatol, 2014, 41 (8): 1650-1655.
[11] Salvador G, Gomez A, Vinas O, et al. Prevalence and clinical significance of anti-cyclic citrullinated peptide and antikeratin antibodies in palindromic rheumatism. An abortive form of rheumatoid arthritis?[J]. Rheumatology (Oxford), 2003, 42(8): 972-975.
[12] Kim SK, Lee HS, Lee KW, et al. Palindromic rheumatism: different genetic background implies a distinct disease entity[J]. Ann Rheum Dis, 2006, 65(11): 1539-1540.
[13] Wang J, Zhang Q, Xu L, et al. A case of episodic and refractory arthritis due to a novel variant of NLRP12[J]. Ann Rheum Dis, 2022, 81(2): e33.
[14] Lu LY, Keng HM, Chu JJ, et al. TNF receptor Ⅰ polymorphism is associated with persistent palindromic rheumatism[J]. Scand J Rheumatol, 2007, 36(4): 278-284.
[15] Mankia K, D'Agostino MA, Wakefield RJ, et al. Identification of a distinct imaging phenotype may improve the management of palindromic rheumatism[J]. Ann Rheum Dis, 2019, 78(1): 43-50.
[16] Pasero G, Barbieri P. Palindromic rheumatism: you just have to think about it![J]. Clin Exp Rheumatol, 1986, 4(3): 197-199.
[17] Guerne PA, Weisman MH. Palindromic rheumatism: part of or apart from the spectrum of rheumatoid arthritis[J]. Am J Med, Oct, 1992, 93(4): 451-460.
[18] Gonzalez-Lopez L, Gamez-Nava JI, Jhangri GS, et al. Prognostic factors for the development of rheumatoid arthritis and other connective tissue diseases in patients with palindromic rheumatism[J]. J Rheumatol, Mar, 26(3): 540-545.
[19] Cañete JD, Arostegui JI, Queiró R, et al. An unexpectedly high frequency of MEFV mutations in patients with anti-citrullinated protein antibody-negative palindromic rheumatism[J]. Arthritis Rheum, 2007, 56(8): 2784-2788.
[20] Salehzadeh F, Barak M, Nematdoust Haghi R. Relapsing periodic arthritis, palindromic rheumatism and MEFV gene-related variants alleles in children[J]. Pediatr Rhe-umatol Online J, 2019, 17(1): 28.
[21] Suganuma Y, Tanaka H, Kawase A, et al. Expression of a PYCARD/ASC variant lacking exon 2 in Japanese patients with palindromic rheumatism increases interleukin-1β secretion[J]. Asian Pac J Allergy Immunol, 2022, 40(1): 81-86.
[22] Eliakim A, Neumann L, Horowitz J, et al. Palindromic rheumatism in Israel-a disease entity?[J]. Clin Rheumatol, 1989, 8(4): 507-511.
[23] Khabbazi A, Mirza-Aghazadeh-Attari M, Goli MT, et al. Is palindromic rheumatism a pre-rheumatoid arthritis condition?[J]. Reumatol Clin (Engl Ed), 2021, 17(1): 7-11.
[24] Kaushik P. Palindromic rheumatism: a descriptive report of seven cases from North Dakota and a short review of literature[J]. Clin Rheumatol, 2010, 29(1): 83-86.
[25] Ueda S, Horino T, Arii K, et al. Magnetic resonance imaging of palindromic rheumatism[J]. Rheumatol Int, 2008, 29(1): 87-89.
[26] Thapa S, Meysami A. Palindromic rheumatism: an unusual cause of chronic intermittent arthritis[J]. Am J Med, 2015, 128 (12): e23-e24.
[27] Corradini D, Di Matteo A, Emery P, et al. How should we treat palindromic rheumatism[J]. Semin Arthritis Rheum, 2021, 51(1): 266-277.
[28] Richardson MR, Zalin AM. Treatment of palindromic rheumatism with chloroquine[J]. Br Med J (Clin Res Ed), 1987, 294(6582): 1289.
[29] Mattingly S. Palindromic rheumatism[J]. Ann Rheum Dis, 1966, 25(4): 307-317.
[30] Brégeon C, Dajon JL, Renier G, et al. Palindromic rheumatism. Immunologic survey and study of development in 43 cases[J]. Rev Rhum Mal Osteoartic, 1986, 53(7-9): 441-449.
[31] Emad Y, Anbar A, Abo-Elyoun I, et al. In palindromic rheumatism, hand joint involvement and positive anti-CCP antibodies predict RA development after 1 year of follow-up[J]. Clin Rheumatol, 2014, 33(6): 791-797.
[32] Youssef W, Yan A, Russell AS. Palindromic rheumatism: a response to chloroquine[J]. J Rheumatol, 1991, 18(1): 35-37.
[33] Gonzalez-Lopez L, Gamez-Nava JI, Jhangri G, et al. Decreased progression to rheumatoid arthritis or other connective tissue diseases in patients with palindromic rheumatism treated with antimalarials[J]. J Rheumatol, 2000, 27(1): 41-46.
[34] Raghavan P, Sreenath S, Cherian S, et al. Efficacy of rituximab in resistant palindromic rheumatism: first report in literature[J]. Clin Rheumatol, 2019, 38(9): 2399-2402.
[35] Schwartzberg M. Prophylactic colchicine therapy in palindromic rheumatism[J]. J Rheumatol, 1982, 9(2): 341-343.
文章导航

/